GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sprint Bioscience AB (OSTO:SPRINT) » Definitions » Price-to-Operating-Cash-Flow

Sprint Bioscience AB (OSTO:SPRINT) Price-to-Operating-Cash-Flow : 5.75 (As of May. 23, 2024)


View and export this data going back to 2014. Start your Free Trial

What is Sprint Bioscience AB Price-to-Operating-Cash-Flow?

As of today (2024-05-23), Sprint Bioscience AB's share price is kr1.306. Sprint Bioscience AB's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was kr0.23. Hence, Sprint Bioscience AB's Price-to-Operating-Cash-Flow Ratio for today is 5.75.

The historical rank and industry rank for Sprint Bioscience AB's Price-to-Operating-Cash-Flow or its related term are showing as below:

OSTO:SPRINT' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 2.53   Med: 29.9   Max: 707.44
Current: 5.75

During the past 13 years, Sprint Bioscience AB's highest Price-to-Operating-Cash-Flow Ratio was 707.44. The lowest was 2.53. And the median was 29.90.

OSTO:SPRINT's Price-to-Operating-Cash-Flow is ranked better than
94.16% of 291 companies
in the Biotechnology industry
Industry Median: 26.38 vs OSTO:SPRINT: 5.75

Sprint Bioscience AB's Cash Flow from Operations per share for the three months ended in Mar. 2024 was kr-0.13. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was kr0.23.

During the past 13 years, Sprint Bioscience AB's highest 3-Year average Operating Cash Flow per Share Growth Rate was 21.90% per year. The lowest was -24.40% per year. And the median was 9.90% per year.


Sprint Bioscience AB Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Sprint Bioscience AB's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sprint Bioscience AB Price-to-Operating-Cash-Flow Chart

Sprint Bioscience AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Operating-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 5.29

Sprint Bioscience AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Price-to-Operating-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - 5.44 5.29 4.54

Competitive Comparison of Sprint Bioscience AB's Price-to-Operating-Cash-Flow

For the Biotechnology subindustry, Sprint Bioscience AB's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sprint Bioscience AB's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sprint Bioscience AB's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Sprint Bioscience AB's Price-to-Operating-Cash-Flow falls into.



Sprint Bioscience AB Price-to-Operating-Cash-Flow Calculation

Sprint Bioscience AB's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio=Share Price/Cash Flow from Operations per share (TTM)
=1.306/0.227
=5.75

Sprint Bioscience AB's Share Price of today is kr1.306.
Sprint Bioscience AB's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0.23.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio=Market Cap/Cash Flow from Operations

Sprint Bioscience AB Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Sprint Bioscience AB's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Sprint Bioscience AB (OSTO:SPRINT) Business Description

Traded in Other Exchanges
Address
Halsovagen 7, Floor 8, Elevator A, Novum, Huddinge, SWE, 141 57
Sprint Bioscience AB is a Sweden based company involved in developing drugs focused on cancer and metabolism. The project portfolio of the company includes STK25, VPS34, and PIP4K2.

Sprint Bioscience AB (OSTO:SPRINT) Headlines

No Headlines